A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2).

Wheeler, Mark D

A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2). [electronic resource] - European journal of pediatrics Oct 2018 - 1497-1503 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

1432-1076

10.1007/s00431-018-3205-z doi


Adolescent
Blood Glucose--drug effects
Child
Diabetes Mellitus, Type 2--drug therapy
Female
Glycated Hemoglobin--drug effects
Humans
Hypoglycemic Agents--adverse effects
Insulin Detemir--adverse effects
Insulin, Isophane--adverse effects
Life Style
Male
Metformin--therapeutic use